Spevigo 50222-0362
Generic: Spesolimab
Product NDC
50222-0362- Manufacturer
- Leo Pharma Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 9, 2026
- Listing Expires
- December 31, 2027
- Application
- BLA761244
Need to source Spevigo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Spesolimab | 300 mg/2mL |
Drug Class
Interleukin-36 Receptor Antagonist [EPC]Interleukin-36 Receptor Antagonist [EPC]Interleukin-36 Receptor Antagonists [MoA]
Packaging Options(2)
1 SYRINGE, GLASS in 1 CARTON (50222-362-01) / 2 mL in 1 SYRINGE, GLASS (50222-362-12)
2 SYRINGE, GLASS in 1 CARTON (50222-362-02) / 2 mL in 1 SYRINGE, GLASS (50222-362-12)